Patents by Inventor David Maloney
David Maloney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240103012Abstract: Provided are methods, kits and compositions related to toxicity associated with administration of cell therapy for the treatment of diseases or conditions, e.g., cancer, including methods for use in predicting and treating a toxicity. In some embodiments, the toxicity is a neurotoxicity or cytokine release syndrome (CRS), such as a severe neurotoxicity or a severe CRS. The methods generally involve detecting a parameter of a biomarker or individually a parameter of each biomarker in a panel of biomarkers, such as a concentration, amount or activity, and comparing the detected parameter to a reference value for the parameter to determine if the subject is at risk for developing the toxicity, such as neurotoxicity or CRS or severe neurotoxicity or severe CRS.Type: ApplicationFiled: September 27, 2023Publication date: March 28, 2024Applicants: Juno Therapeutics, Inc., Fred Hutchinson Cancer Research CenterInventors: He LI, Mark J. GILBERT, David MALONEY, Stanley R. RIDDELL, Cameron J. TURTLE
-
Patent number: 11815514Abstract: Provided are methods, kits and compositions related to toxicity associated with administration of cell therapy for the treatment of diseases or conditions, e.g., cancer, including methods for use in predicting and treating a toxicity. In some embodiments, the toxicity is a neurotoxicity or cytokine release syndrome (CRS), such as a severe neurotoxicity or a severe CRS. The methods generally involve detecting a parameter of a biomarker or individually a parameter of each biomarker in a panel of biomarkers, such as a concentration, amount or activity, and comparing the detected parameter to a reference value for the parameter to determine if the subject is at risk for developing the toxicity, such as neurotoxicity or CRS or severe neurotoxicity or severe CRS.Type: GrantFiled: December 2, 2016Date of Patent: November 14, 2023Assignees: Juno Therapeutics, Inc., Fred Hutchinson Cancer Research CenterInventors: He Li, Mark J. Gilbert, David Maloney, Stanley R. Riddell, Cameron J. Turtle
-
Patent number: 11426415Abstract: The present invention generally relates to compositions and methods for treating or preventing an endoplasmic reticulum stress disorder in subjects, including compositions and methods for treating or preventing Wolfram syndrome. The present invention also relates to methods for treating symptoms of neurodegenerative diseases.Type: GrantFiled: March 6, 2018Date of Patent: August 30, 2022Assignees: Washington University, The United States of America, As Represented by the Secretary, Department of Health and Human ServicesInventors: Fumihiko Urano, Jana Mahadevan, Amy Clark, Ajit Jadhav, David Maloney, Brandon Harvey, Shyh-ming Yang, Mark Henderson
-
Publication number: 20220270464Abstract: Disclosed embodiments may include an air quality measuring system for determining the environmental risk of indoor pollutants to occupants. The system may include sensors for monitoring a number of airborne pollutants and pathogens. The system may allow a user to interact with the system by scanning a QR code. The system may display, on a user's mobile device, the amount of airborne pollutants in an indoor space. The system may allow the user to share the system's readings by a link, social media post, or public ratings website. The system may be capable of interacting with building smart systems, fire alarms, and HVAC systems. The system may also be capable of sounding an alarm if air quality thresholds are outside a normal range.Type: ApplicationFiled: February 22, 2022Publication date: August 25, 2022Inventors: Carl Henly TAUTENHAHN, Kevin David MALONEY, Gerald Monroe TAUTENHAHN
-
Publication number: 20220177422Abstract: Disclosed herein is a class of molecules termed remodilins that are effective in treating asthma, pulmonary fibrosis, and associated disorders. The molecules ameliorate asthma and pulmonary fibrosis symptoms by various mechanisms, including inhibiting airway smooth muscle contractile protein accumulation, reducing airway constrictor hyperresponsiveness, inhibiting bronchial fibroblast transformation into myofibroblasts, and/or treating or preventing airway or pulmonary fibrosis.Type: ApplicationFiled: April 2, 2020Publication date: June 9, 2022Applicants: The University of Chicago, The United States of America,as Represented by the Secretary, Department of Health and Human Servic, President and Fellows of Harvard College, IIT Research Institute, Beth Israel Deaconess Medical Center, Inc.Inventors: Julian SOLWAY, Nickolai DULIN, Diane Luci, David MALONEY, Chan Young PARK, Jeffrey FREDBERG, David MCCORMICK, Ramaswamy KRISHNAN
-
Patent number: 11284711Abstract: A mobile workstation comprises a wheeled base, a height-adjustable post assembly fixedly coupled to the rear end of the wheeled base, and a tray assembly fixedly coupled to the top of the post assembly. The post assembly has a four-post construction, with upper and lower vertical posts pivotally connected to a pair of linking posts. To accommodate different users, the post assembly is designed to articulate between an upper position and a lower position through a primarily vertical travel path. The four-post construction of the post assembly disperses the weight of the tray assembly, thereby reducing the manual force required to implement height adjustment. The planar, primarily vertical, travel path undertaken by the post assembly during height adjustment maintains the workstation center of gravity to a centralized location in the base, thereby minimizing the use of counterbalances to ensure stability. As a result, the workstation is lightweight and easily maneuverable.Type: GrantFiled: February 22, 2019Date of Patent: March 29, 2022Assignee: JACO, INC.Inventors: Alfred P. Rossini, Thomas J. Bagley, Govind Patel, David Maloney, Jeff Silverman
-
Publication number: 20220073470Abstract: This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating or preventing inappropriate activation of a type I interferon (IFN) response in a subject in need thereof.Type: ApplicationFiled: January 3, 2020Publication date: March 10, 2022Inventors: Robert G. Lowery, Meera Kumar, Matthew Boxer, David Maloney, Susan Boyd
-
Publication number: 20220073532Abstract: This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating or preventing inappropriate activation of a type I interferon (IFN) response in a subject in need thereof.Type: ApplicationFiled: January 3, 2020Publication date: March 10, 2022Inventors: Robert G. Lowery, Meera Kumar, Matthew Boxer, David Maloney, Susan Boyd
-
Publication number: 20220040207Abstract: Disclosed herein is a class of molecules termed remodilins that inhibit serum response factor (SRF). By inhibiting SRF, a number of downstream pathways can be targeted. The remodilins can be used to treat glaucoma, inhibit tumor cell growth, inhibit tumor metastasis, inhibit hypoxia-induced response, and/or reduce cellular metabolism.Type: ApplicationFiled: April 2, 2020Publication date: February 10, 2022Applicants: The University of Chicago, The United States of America as Represented by the Secretary Department of Health and Human Services, President and Fellows of Harvard College, IIT Research Institute, Beth Israel Deaconess Medical Center, Inc.Inventors: Julian SOLWAY, Nickolai DULIN, Marsha ROSNER, Gokhan MUTLU, Diane LUCI, David MALONEY, Chan Young PARK, Jeffrey FREDBERG, David MCCORMICK, Ramaswamy KRISHNAN
-
Publication number: 20210128580Abstract: The present invention generally relates to compositions and methods for treating or preventing an endoplasmic reticulum stress disorder in subjects, including compositions and methods for treating or preventing Wolfram syndrome. The present invention also relates to methods for treating symptoms of neurodegenerative diseases.Type: ApplicationFiled: March 6, 2018Publication date: May 6, 2021Applicants: Washington University, The United States of America, As Represented by the Secretary, Department Health and Human ServiceInventors: Fumihiko Urano, Jana Mahadevan, Amy Clark, Ajit Jadhav, David Maloney, Brandon Harvey, Shyh-ming Yang, Mark Henderson
-
Publication number: 20200016199Abstract: Provided are adoptive cell therapy methods involving the administration of doses of cells for treating B cell malignancies. The cells generally express recombinant receptors such as chimeric antigen receptors (CARs). In some embodiments, the methods are for treating subjects with chronic lymphocytic leukemia (CLL). In some embodiments, the methods are for treating subjects with non-Hodgkin lymphoma (NHL). In some embodiments, the methods involve prior administration of a lymphodepleting therapy, such as prior administration of fluradibine and/or another lymphodepleting chemotherapeutic agent, for example cyclophosphamide. In some embodiments, features of the methods include an increase in complete remission, overall survival and/or progression free survival of subjects treated in accord with the provided methods.Type: ApplicationFiled: June 6, 2017Publication date: January 16, 2020Applicants: Juno Therapeutics, Inc., Fred Hutchinson Canser Research CenterInventors: Cameron J. TURTLE, David MALONEY, Stanley R. RIDDELL, Mark Gilbert
-
Publication number: 20190277858Abstract: Provided are methods, kits and compositions related to toxicity associated with administration of cell therapy for the treatment of diseases or conditions, e.g., cancer, including methods for use in predicting and treating a toxicity. In some embodiments, the toxicity is a neurotoxicity or cytokine release syndrome (CRS), such as a severe neurotoxicity or a severe CRS. The methods generally involve detecting a parameter of a biomarker or individually a parameter of each biomarker in a panel of biomarkers, such as a concentration, amount or activity, and comparing the detected parameter to a reference value for the parameter to determine if the subject is at risk for developing the toxicity, such as neurotoxicity or CRS or severe neurotoxicity or severe CRS.Type: ApplicationFiled: December 2, 2016Publication date: September 12, 2019Applicants: Juno Therapeutics, Inc., Fred Hutchinson Cancer Research CenterInventors: He LI, Mark J. GILBERT, David MALONEY, Stanley R. RIDDELL, Cameron J. TURTLE
-
Publication number: 20190254420Abstract: A mobile workstation comprises a wheeled base, a height-adjustable post assembly fixedly coupled to the rear end of the wheeled base, and a tray assembly fixedly coupled to the top of the post assembly. The post assembly has a four-post construction, with upper and lower vertical posts pivotally connected to a pair of linking posts. To accommodate different users, the post assembly is designed to articulate between an upper position and a lower position through a primarily vertical travel path. The four-post construction of the post assembly disperses the weight of the tray assembly, thereby reducing the manual force required to implement height adjustment. The planar, primarily vertical, travel path undertaken by the post assembly during height adjustment maintains the workstation center of gravity to a centralized location in the base, thereby minimizing the use of counterbalances to ensure stability. As a result, the workstation is lightweight and easily maneuverable.Type: ApplicationFiled: February 22, 2019Publication date: August 22, 2019Inventors: Alfred P. Rossini, Thomas J. Bagley, Govind Patel, David Maloney, Jeff Silverman
-
Publication number: 20190110112Abstract: A system for automatically presenting video of a sporting event tracks competitors automatically and presents the video stream to a subscriber interface. The system automatically switches between streams as the competitor changes events. The subscriber interface may have elements to present a call to action to the user.Type: ApplicationFiled: October 8, 2018Publication date: April 11, 2019Inventor: David Maloney
-
Patent number: 9858073Abstract: The present application provides a method of randomly accessing a compressed structure in memory without the need for retrieving and decompressing the entire compressed structure.Type: GrantFiled: February 11, 2009Date of Patent: January 2, 2018Assignee: LINEAR ALGEBRA TECHNOLOGIES LIMITEDInventor: David Maloney
-
Patent number: 9301117Abstract: Systems and methods provide, to emergency operators at an emergency call center, the ability to communicate through textual messages with wireless mobile devices from which emergency voice calls have been placed. By virtue of such textual communication, callers using wireless mobile devices can receive emergency instructions and/or provide information about their current location.Type: GrantFiled: August 21, 2013Date of Patent: March 29, 2016Assignee: TRITECH SOFTWARE SYSTEMSInventors: David J. Leggett, Christopher David Maloney, Scott Michael MacDonald, Mark David Hamilton, Erik Christian Loberg, Chen-Lu Meng, Ken D. Martin
-
Patent number: 9291192Abstract: A connecting rod of an internal combustion engine, that includes a large bore, and an interior bore surface. The current art uses soft metal bearing surfaces to reduce wear, and friction between the connecting rod inner diameter and the crankshaft journal surface. The soft metal bearing surface is a separate component of the engine. In this invention the large bore end interior diameter is coated with a hard material to reduce, or eliminate wear. The hard material is a metal or metal alloy applied to the inner diameter by a thermal spray method. A relatively soft polymer material can also be applied to the interior diameter surface of the con-rod bore. The relatively softer polymer acts as a first and sometimes a consumable layer, and applied over the thermal sprayed hard layer. The polymer layer is often used in conjunction with the sprayed metal layer.Type: GrantFiled: June 16, 2014Date of Patent: March 22, 2016Assignee: Mahle International GmbHInventors: Ronald G. Brock, II, Viviane Morais, Joachim Wagenblast, David Maloney
-
Publication number: 20150056946Abstract: Systems and methods provide, to emergency operators at an emergency call center, the ability to communicate through textual messages with wireless mobile devices from which emergency voice calls have been placed. By virtue of such textual communication, callers using wireless mobile devices can receive emergency instructions and/or provide information about their current location.Type: ApplicationFiled: August 21, 2013Publication date: February 26, 2015Applicant: TRITECH SOFTWARE SYSTEMSInventors: David J. Leggett, Christopher David Maloney, Scott Michael MacDonald, Mark David Hamilton, Erik Christian Loberg, Chen-Lu Meng, Ken D. Martin
-
Publication number: 20140366833Abstract: A connecting rod of an internal combustion engine, that includes a large bore, and an interior bore surface. The current art uses soft metal bearing surfaces to reduce wear, and friction between the connecting rod inner diameter and the crankshaft journal surface. The soft metal bearing surface is a separate component of the engine. In this invention the large bore end interior diameter is coated with a hard material to reduce, or eliminate wear. The hard material is a metal or metal alloy applied to the inner diameter by a thermal spray method. A relatively soft polymer material can also be applied to the interior diameter surface of the con-rod bore. The relatively softer polymer acts as a first and sometimes a consumable layer, and applied over the thermal sprayed hard layer. The polymer layer is often used in conjunction with the sprayed metal layer.Type: ApplicationFiled: June 16, 2014Publication date: December 18, 2014Inventors: Ronald Brock, Viviane Morais, Joachim Wagenblast, David Maloney
-
Patent number: D883602Type: GrantFiled: July 2, 2018Date of Patent: May 5, 2020Assignee: JACO, INC.Inventors: Alfred P. Rossini, Thomas J. Bagley, Govind Patel, David Maloney, Jeff Silverman